Showing results (1711-1720 of 5,935) with videos related to

Sort By:
Pageof 594
The Prostate|July 17, 2015
Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selectionGiorgio Gandaglia, Jonas Schiffmann, Thorsten Schlomm, et al.
The Prostate|July 17, 2015
PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomasCarlos L Morais, Mehsati Herawi, Antoun Toubaji, et al.
The Prostate|July 18, 2015
Chronic baseline prostate inflammation is associated with lower tumor volume in men with prostate cancer on repeat biopsy: Results from the REDUCE studyDaniel M Moreira, J Curtis Nickel, Gerald L Andriole, et al.
The Prostate|July 18, 2015
Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influencesFabio Montico, Larissa Akemi Kido, Rebeca San Martin, et al.
The Prostate|July 18, 2015
Clinical significance of proliferative inflammatory atrophy finding in prostatic biopsiesPol Servian, Ana Celma, Jacques Planas, et al.
The Prostate|July 17, 2015
Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathwayChen-Hsun Ho, Jui-Ling Hsu, Shih-Ping Liu, et al.
The Prostate|August 29, 2025
Directed Evolution Restored Castrate Sensitivity in a Patient With Castrate Resistant Metastatic Prostate CancerRobert A Gatenby, Alexander R A Anderson, Joel S Brown, et al.
The Prostate|January 1, 1985
Characterization of the heterogeneity of R3327 rat prostatic tumors derived from single-cell clonesS A Thompson, M P Johnson, P M Heidger, et al.
The Prostate|January 1, 1985
Chronic prostatitis: comments on infectious etiologies and antimicrobial treatmentR N Greenberg, P M Reilly, K L Luppen, et al.
The Prostate|September 4, 2025
Prostate-Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone-Sensitive Prostate Cancer Treated With ApalutamideChristian Andrés Martínez Osorio, Raquel Sopeña Sutil, Antoni Vilaseca Cabo, et al.
Pageof 594